Total Payments
$468.47
2024 Payments
$168.57
Companies
14
Transactions
27
Medicare Patients
1,401
Medicare Billing
$68,447
Payment Breakdown by Category
Food & Beverage$454.47 (97.0%)
Education$14.00 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $454.47 | 26 | 97.0% |
| Education | $14.00 | 1 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $120.47 | 7 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $88.74 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $36.08 | 2 | $0 (2024) |
| GENZYME CORPORATION | $35.56 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $34.71 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $32.24 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.67 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $15.01 | 1 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $14.06 | 1 | $0 (2023) |
| Dermavant Sciences, Inc. | $14.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $168.57 | 10 | SUN PHARMACEUTICAL INDUSTRIES INC. ($69.71) |
| 2023 | $82.76 | 5 | Novartis Pharmaceuticals Corporation ($22.18) |
| 2022 | $136.48 | 7 | ABBVIE INC. ($52.35) |
| 2021 | $80.66 | 5 | AbbVie Inc. ($68.12) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Immunology | ||||||
| 08/16/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $8.67 | General |
| Category: DERMATOLOGY | ||||||
| 07/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Dermatology | ||||||
| 05/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Dermatology | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Dermatology | ||||||
| 02/22/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $4.47 | General |
| Category: DERMATOLOGY | ||||||
| 02/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Dermatology | ||||||
| 12/05/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Immunology | ||||||
| 08/16/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Dermatology | ||||||
| 07/06/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Education | In-kind items and services | $14.00 | General |
| Category: DERMATOLOGY | ||||||
| 05/15/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.06 | General |
| 04/18/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Dermatology | ||||||
| 11/01/2022 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: Immunology | ||||||
| 09/25/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: DERMATOLOGY | ||||||
| 09/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Immunology | ||||||
| 03/03/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: IMMUNOLOGY | ||||||
| 09/15/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $17.94 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 846 | 1,380 | $209,493 | $50,585 |
| 2020 | 10 | 555 | 813 | $86,307 | $17,862 |
Total Patients
1,401
Total Services
2,193
Medicare Billing
$68,447
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 207 | 207 | $54,400 | $13,249 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 74 | $22,333 | $5,835 | 26.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 128 | 175 | $27,563 | $5,683 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 103 | $21,934 | $5,645 | 25.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 84 | 98 | $23,302 | $5,480 | 23.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 55 | 66 | $17,389 | $4,408 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $13,733 | $3,322 | 24.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 93 | 512 | $9,347 | $2,094 | 22.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 42 | 42 | $7,140 | $1,668 | 23.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $5,451 | $1,397 | 25.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 28 | $3,716 | $955.26 | 25.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 27 | $3,184 | $848.63 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 99 | $16,608 | $3,750 | 22.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 118 | 129 | $13,685 | $3,482 | 25.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 52 | 54 | $9,720 | $2,633 | 27.1% |
| 17000 | Destruction of skin growth | Office | 2020 | 91 | 98 | $14,037 | $2,149 | 15.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 40 | 41 | $6,733 | $1,966 | 29.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 41 | 41 | $8,190 | $1,571 | 19.2% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 63 | 298 | $11,964 | $953.26 | 8.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 14 | 15 | $1,385 | $476.98 | 34.4% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 16 | 16 | $2,180 | $468.21 | 21.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 21 | 22 | $1,805 | $412.60 | 22.9% |
About Mandy Wever, FNP
Mandy Wever, FNP is a Nurse Practitioner healthcare provider based in Bloomington, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1316220296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mandy Wever, FNP has received a total of $468.47 in payments from pharmaceutical and medical device companies, with $168.57 received in 2024. These payments were reported across 27 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($454.47).
As a Medicare-enrolled provider, Wever has provided services to 1,401 Medicare beneficiaries, totaling 2,193 services with total Medicare billing of $68,447. Data is available for 2 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Bloomington, IN
- Active Since 09/27/2011
- Last Updated 05/04/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1316220296
Products in Payments
- Winlevi (Drug) $88.74
- DUPIXENT (Biological) $70.27
- SKYRIZI (Biological) $63.37
- TREMFYA (Drug) $47.25
- RINVOQ (Biological) $39.16
- COSENTYX (Drug) $36.08
- SPEVIGO (Drug) $26.67
- VTAMA (Drug) $14.00
- Sotyktu (Drug) $13.49
- AMELUZ (Drug) $13.14
- TALTZ (Drug) $12.54
- ADBRY (Biological) $11.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Bloomington
Theresa Woodard, Np, NP
Nurse Practitioner — Payments: $11,140
Nurse Practitioner $11,140
Susan Stolz, Np, NP
Nurse Practitioner — Payments: $4,302
Nurse Practitioner $4,302
Staci Murphy, Fnp, Pnp, FNP, PNP
Nurse Practitioner — Payments: $2,359
Nurse Practitioner $2,359
Amber Kingery
Nurse Practitioner — Payments: $2,003
Nurse Practitioner $2,003
Courtney Moore, Np, NP
Nurse Practitioner — Payments: $1,782
Nurse Practitioner $1,782
Mrs. Tiffany Mcintyre, Np-C, NP-C
Nurse Practitioner — Payments: $1,592
Nurse Practitioner $1,592